WuXi Biologics kicks off $20m ADC build in China
WuXi Biologics has started building its antibody-drug conjugate (ADC) centre in Wuxi City, China, where it will offer biologics conjugate services for clients.
Archives for June 20, 2018
AbSci aims to tackle the antibody market after raising $12m to scale E. coli-based tech
With $12m in Series C financing, AbSci is looking to tackle the antibody market by accelerating innovation and driving down manufacturing costs using its synthetic biology platform, says CEO.